EyePoint Pharmaceuticals, Inc. Gains 177.46%
Mon, Dec 04, 2023 at 07:40 PM
EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ) rocketted at $18.34, representing a gain of 177.5%. On Mon, Dec 04, 2023, EYPT:NASDAQ hit a New 2-Week High of $18.34. The stock got featured on our News Catalysts scanner on Mon, Dec 04, 2023 at 07:08 PM in the 'PUBLIC OFFERING' category. From Mon, Nov 20, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
About EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ)
pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 506.06%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 240.33%
- Hawaiian Holdings, Inc. (HA:NASDAQ), 192.59%
- EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ), 177.46%
- Alterity Therapeutics Limited (ATHE:NYSE), 153.01%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 153.01%
- View Inc. (VIEW:NASDAQ), 66.99%
- Lucy Scientific Discovery Inc. (LSDI:NASDAQ), 66.83%
- enGene Holdings Inc. (ENGN:NASDAQ), 64.13%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 59.33%